Inherited prothrombotic risk factors in children with stroke, transient ischemic attack, or migraine

Pediatrics

Volumn 123, Issue 4, 2009, Pages

  Herak, Désirée Coen ^a   Antolic, Margareta Radic ^a   Krleza, Jasna Lenicek ^b   Pavic, Marina ^a   Dodig, Slavica ^c   Duranovic, Vlasta ^b   Brkic, Anica Basnec ^a   Zadro, Renata ^a  

^a KBC Zagreb   (Croatia)

^b Croatia   (Croatia)

^c Special Hospital for Respiratory Diseases in Children and Adolescents   (Croatia)

Author keywords

Children; Genetic polymorphism; Inherited prothrombotic risk factor; Migraine; Stroke; Transient ischemic attack

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALLOANTIGEN; BLOOD CLOTTING FACTOR 5; PROTHROMBIN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); THROMBOCYTE ANTIGEN;

ALLELE; ARTICLE; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; ADOLESCENT; BRAIN ISCHEMIA; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; INFANT; OCCLUSIVE CEREBROVASCULAR DISEASE; PREVALENCE;

ADOLESCENT; ANTIGENS, HUMAN PLATELET; BRAIN ISCHEMIA; CHILD; CHILD, PRESCHOOL; FACTOR V; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INTRACRANIAL THROMBOSIS; ISCHEMIC ATTACK, TRANSIENT; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIGRAINE DISORDERS; POLYMORPHISM, GENETIC; PREVALENCE; PROTHROMBIN; RISK FACTORS; STROKE;

EID: 65349114716     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-3737     Document Type: Article

References (48)

1. Lynch JK. Cerebrovascular disorders in children. Curr Neurol Neurosci Rep. 2004;4(2):129-138 (Pubitemid 38899064)
2. Sofronas M, Ichord RN, Fullerton HJ, et al. Pediatric stroke initiatives and preliminary studies: what is known and what is needed? Pediatr Neurol. 2006;34(6):439-445 (Pubitemid 43831575)
3. Nowak-Göttl U, Günther G, Kurnik K, Strater R, Kirkham F. Arterial ischemic stroke in neonates, infants and children: an overview of underlying conditions, imaging methods, and treatment modalities. Semin Thromb Hemost. 2003;29(4): 405-414 (Pubitemid 37059767)
4. Merikangas KR, Febton BT, Cheng SH, Stolar MJ, Risch N. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol. 1997; 54(4):362-368 (Pubitemid 27172854)
5. Bassi B, Parodi E, Messina M, et al. Screening for genetic and acquired thrombophilia in a cohort of young migrainous patients. J Headache Pain. 2003;4(3):138-145 (Pubitemid 38029030)
6. Kirkham FJ. Is there a genetic basis for pediatric stroke? Curr Opin Pediatr. 2003;15(6):547-558 (Pubitemid 37487368)
7. Barnes C, deVeber G. Prothrombotic abnormalities in childhood ischaemic stroke. Thromb Res. 2006;118(1):67-74
8. Santoso S. Human platelet alloantigens. Transfus Apher Sci. 2003;28(3):227-236 (Pubitemid 36506496)
9. Deckmyn H, Ulrichts H, Van de Walle G, Vanhoorelbeke K. Platelet antigens and their function. Vox Sang. 2004;87(suppl 2):S105-S111 (Pubitemid 39165286)
10. 33 amino acid polymorphism in membrane glycoprotein IIIa and are distinguishable by DNA typing. J Clin Invest. 1989;83(5): 1778-1781
11. 145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest. 1992;89(2): 381-384
12. b alloantigen system. Blood. 1990;75(12): 2343-2348
13. b, are associated with a single amino acid polymorphism on glycoprotein Ia (integrin α2). J Clin Invest. 1993;92(5): 2427-2432
14. Sébire G, Fullerton H, Riou E, deVeber G. Toward the definition of cerebral arteriopathies of childhood. Curr Opin Pediatr. 2004;16(6):617-622 (Pubitemid 39552209)
15. International Headache Society, Headache Classification Subcommittee. The International Classification of Headache Disorders, 2nd edition. Cephalagia. 2004;24(suppl 1):1-160
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215
17. Zöller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest. 1994;94(6):2521-2524 (Pubitemid 24379631)
18. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996; 88(10):3698-3703 (Pubitemid 26383091)
19. Aslanidis C, Nauck M, Schmitz G. High-speed prothrombin G→A 20210 and methylenetetrahydrofolate reductase C→T 677 mutation detection using real-time fluorescence PCR and melting curves. Biotechniques. 1999;27(2):234-238 (Pubitemid 29382379)
20. Klüter H, Fehlau K, Panzer S, Kirchner H, Bein G. Rapid typing for human platelet antigen systems-1, -2, -3 and -5 by PCR amplification with sequence-specific primers. Vox Sang. 1996; 71(2):121-125 (Pubitemid 26288277)
21. Nowak-Göttl U, Sträter R, Heinecke A, et al. Lipoprotein(a) and genetic polymorphisms of clotting factor V, prothrombin and methylenetetrahydrofolate reductase are risk factors of ischemic stroke in childhood. Blood. 1999;94(11):3678-3682
22. Kenet G, Sadetzki S, Murad H, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000;31(6):1283-1288 (Pubitemid 30351246)
23. Hagstrom JN, Walter J, Bluebond-Langner R, Amatniek JC, Manno CS, High KA. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr. 1998;133(6):777-781 (Pubitemid 28563948)
24. Akar N, Akar E, Yilmaz E, Deda G. Plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish children with cerebral infarct and effect on factor V 1691A mutation. J Child Neurol. 2001;16(4):294-295 (Pubitemid 32452007)
25. Zenz W, Bodo Z, Plotho J, et al. Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thromb Haemost. 1998;80(5):763-766 (Pubitemid 28521719)
26. McColl MD, Chalmers EA, Thomas A, et al. Factor V Leiden, prothrombin 20210G→A and the MTHFR C677T mutations in childhood stroke. Thromb Haemost. 1999;81(5):690-694 (Pubitemid 29216551)
27. Barreirinho S, Ferro A, Santos M, et al. Inherited and acquired risk factors and their combined effects in pediatric stroke. Pediatr Neurol. 2003;28(2):134-138 (Pubitemid 36434160)
28. Bonduel M, Sciuccati G, Hepner M, et al. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol. 2003;73(2): 81-86 (Pubitemid 36578428)
29. Miller SP, Wu YW, Lee J, et al. Candidate gene polymorphisms do not differ between newborns with stroke and normal controls. Stroke. 2006;37(11):2678-2683
30. Komitopoulou A, Platokouki H, Kapsimali Z, Pergantou H, Adamtziki E, Aronis S. Mutations and polymorphisms in genes affecting hemostasis proteins and homocysteine metabolism in children with arterial ischemic stroke. Cerebrovasc Dis. 2006; 22(1):13-20 (Pubitemid 43875155)
31. Günther G, Junker R, Strater R, et al. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombic risk factors. Stroke. 2000;31(10):2437-2441
32. Mercuri E, Cowan F, Gupte G, et al. Prothrombic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. Pediatrics. 2001;107(6): 1400-1404 (Pubitemid 32525223)
33. Prengler M, Sturt N, Krywawych S, Surtees R, Liesner R, Kirkham F. Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: a potential risk factor for hyperhomocysteinaemia, CVD, and stroke in childhood. Dev Med Child Neurol. 2001;43(4):220-225 (Pubitemid 32328195)
34. Cardo E, Monros E, Colome C, et al. Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. J Child Neurol. 2000;15(5): 295-298 (Pubitemid 30341360)
35. Lynch JK, Han CJ, Nee LE, Nelson KB. Prothrombotic factors in children with stroke or porencephaly. Pediatrics. 2005; 116(2):447-453 (Pubitemid 44161473)
36. Akar N, Akar E, Deda G, Sipahi T, Orsal A. Factor V 1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct. J Child Neurol. 1999;14(11):749-751
37. Corral J, Iniesta JA, González-Conejero R, Villalón M, Vicente V. Polymorphisms of clotting factors modify the risk of primary intracranial hemorrhage. Blood. 2001;97(10): 2979-2982
38. Sazci A, Ergul E, Tuncer N, Akpinar G, Kara I. Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: dual effect of MTHFR polymorphisms C677T and A1298C. Brain Res Bull. 2006; 71(1-3):45-50
39. Reiner AP, Kumar PN, Schwartz SM, et al. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke. 2000;31(7):1628-1633 (Pubitemid 30437514)
40. Iniesta JA, González-Conejero R, Piqueras C, Vicente V, Corral J. Platelet GP IIIa polymorphism HPA-1 (PIA) protects against subarachnoid hemorrhage. Stroke. 2004;35(10): 2282-2286 (Pubitemid 39311250)
41. Fullerton HJ, Wu YW, Zhao S, Johnston SC. Risk of stroke in children: ethnic and gender disparities. Neurology. 2003;61(2): 189-194 (Pubitemid 36875299)
42. Lewis DW. Toward the definition of childhood migraine. Curr Opin Pediatr. 2004;16(6):628-636 (Pubitemid 39552211)
43. Sonoda A, Murata M, Ito D, et al. Association between platelet glycoprotein Ibα genotype and ischemic cerebrovascular disease. Stroke. 2000;31(2):493-497 (Pubitemid 30078188)
44. Gonzalez-Conejero R, Lozano ML, Rivera J, et al. Polymorphism of platelet glycoprotein Ibα associated with arterial thrombotic disease. Blood. 1998;92(8):2771-2776 (Pubitemid 28469091)
45. Kroll H, Gardemann A, Fechter A, Haberbosch W, Santoso S. The impact of the glycoprotein Ia receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction. Thromb Haemost. 2000;83(3):392-396 (Pubitemid 30148350)
46. Soriani S, Borgna-Pignatti C, Trabetti E, Casartelli A, Montagna P, Pignatti PF. Frequency of factor V Leiden in juvenile migraine with aura. Headache. 1998;38(10):779-781 (Pubitemid 29031075)
47. Bottini F, Celle ME, Calevo MG, et al. Metabolic and genetic risk factors for migraine in children. Cephalalgia. 2006;26(6):731-737 (Pubitemid 43909245)
48. Corral J, Iniesta JA, Gonzales-Conejero R, Lonzano ML, Rivera J, Vincente V. Migraine and prothrombotic genetic risk factors. Cephalalgia. 1998;18(5):257-260 (Pubitemid 28322620)